MétaCan
Menu
Back to cohort
Record W4412962385 · doi:10.14740/jcgo1501

Novel Multimodal Radiofrequency Therapy for Mixed Urinary Incontinence: A Pilot Study

2025· article· en· W4412962385 on OpenAlexvenueno aff
Pablo González Isaza, Diana Vélez Rizo

Bibliographic record

VenueJournal of Clinical Gynecology and Obstetrics · 2025
Typearticle
Languageen
FieldMedicine
TopicPelvic floor disorders treatments
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineUrinary incontinenceMultimodal therapyUrologyPhysical therapyInternal medicine

Abstract

fetched live from OpenAlex

Background: Mixed urinary incontinence (MUI) significantly affects patients’ quality of life (QOL) and poses a therapeutic challenge owing to its multifactorial etiology. Traditional treatments, including pharmacotherapy and surgery, often yield suboptimal outcomes or entail considerable risk. This study aimed to evaluate the efficacy and safety of a novel multimodal radiofrequency (MMRF) therapy for improving MUI symptoms, QOL and histological markers of pelvic tissue integrity. Methods: A prospective pilot study was conducted on 20 female patients diagnosed with MUI. Participants underwent MMRF therapy, which consisted of two modalities: Morpheus V, delivering fractional radiofrequency energy, and Forma V, providing bipolar energy for superficial tissue tightening (Empower Bipolar Radiofrequency Platform InMode Aesthetics, Lake Forest, California, Serial Number R30326211). Treatment was administered over two to three sessions with follow-up at 3 and 6 months. Subjective outcomes were assessed using validated scales, including the International Consultation on Incontinence Questionnaire-Short Form (ICQ-SF), Potenziani scale, overactive bladder symptom score (OAB-SS), and QOL measures using a visual analog scale (0 - 10). Punch biopsies from the anterior vaginal wall were obtained at baseline and at 6 months to evaluate histological changes. Statistical analyses were performed to determine the significance of the pretreatment and posttreatment differences. Results: Twenty participants were included in this study. ICQ-SF scores decreased from 14.05 ± 4.22 at baseline to 10.05 ± 3.79 at 3 months and 7.65 ± 4.44 at 6 months (P < 0.01). The Potenziani and OAB-SS scores exhibited similar reductions, indicating enhanced bladder control and urgency relief (P < 0.001). QOL improved significantly, with mean QOL scores declining from 6.00 ± 1.03 at baseline to 2.95 ± 0.94 at 6 months (P < 0.001). Histological analyses revealed increased collagen density, enhanced vascularization, and reduced inflammatory infiltrates, supporting tissue remodeling and functional recovery. Conclusions: MMRF therapy is a safe, effective and minimally invasive treatment for MUI that addresses both the structural and functional contributors to incontinence. Significant improvements in symptom severity, QOL, and tissue integrity position of MMRF are promising non-surgical options for managing pelvic floor dysfunction. Further research with larger populations and extended follow-up is recommended to confirm these findings and to establish MMRF as a standard treatment for MUI.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Non-randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.010

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.000
Open science0.0010.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.069
GPT teacher head0.397
Teacher spread0.329 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNon-randomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Gynecology and ObstetricsSame topicPelvic floor disorders treatmentsFrench-language works237,207